OBEXELIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

OBEXELIMAB

Official Name

English

XMAB5871 (HUMANIZED ANTI-CD19 ANTIBODY WITH AN FC PORTION ENGINEERED FOR INCREASED AFFINITY (200- TO 400-FOLD OVER NATIVE IGG) TO FCGRIIB)

Common Name

English

OBEXELIMAB [USAN]

Common Name

English

XMAB5871

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB5871 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XMAB5871 LIGHT CHAIN, DIMER

Systematic Name

English

obexelimab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD19 (DIFFERENTIATION ANTIGEN CD19T-CELL SURFACE ANTIGEN LEU-12))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-451) (MUS MUSCULUS VH (IGHV1-14*01 (78%) (IGHD)-IGHJ4*01 (100%))

Systematic Name

English

XMAB-5871

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

566516

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

Code System Code Type Description

USAN

FG-171

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

PRIMARY

DRUG BANK

DB15032

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

PRIMARY

INN

10898

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

PRIMARY

FDA UNII

RM16A4BA8R

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

PRIMARY

CAS

1958118-77-8

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

NO STRUCTURE GIVEN

CAS

1690307-05-1

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

PRIMARY

NCI_THESAURUS

C170236

Created by admin on Sat Dec 16 14:23:27 GMT 2023 , Edited by admin on Sat Dec 16 14:23:27 GMT 2023

PRIMARY

ACTIVE MOIETY


					RM16A4BA8R